As Congress ramps up efforts to rein in the power of pharmacy benefits managers as a way to address the rising cost of prescription drugs, some House Republicans have pushed back on those efforts to say lawmakers should focus on more pressing issues, such as the looming government shutdown.

Recommended Stories

Comer must face ethics investigation for Biden inquiry fundraising: Democratic group

Trump outlines new ‘Great Healthcare Plan’ for Congress

Drugmakers hike prices to start year as threats to industry loom